Clinical Trials on C反应蛋白 in Hong Kong
总计188个结果
-
Humanity and Health Research CentreUniversity of Maryland; Emory University; Beijing 302 Hospital撤销
-
Humanity and Health Research CentreEmory University; Beijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University完全的
-
The Hong Kong Polytechnic UniversityHOYA Lamphun Ltd; Centre for Eye and Vision Research招聘中
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University招聘中
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong完全的
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong完全的
-
The Hong Kong Polytechnic UniversityShamir Optical Industry Ltd终止
-
Technolas Perfect Vision GmbH未知
-
The Hong Kong Polytechnic UniversityQueensland University of Technology; Menicon Co., Ltd.终止
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology招聘中
-
The Hong Kong Polytechnic UniversityMenicon Co., Ltd.完全的
-
AstraZeneca终止升高的高灵敏度 C 反应蛋白 (hsCRP)美国, 巴西, 保加利亚, 波兰, 俄罗斯联邦, 南非, 英国, 德国, 爱沙尼亚, 罗马尼亚, 丹麦, 荷兰, 挪威, 加拿大, 墨西哥, 比利时, 以色列, 波多黎各, 哥伦比亚, 阿根廷, 委内瑞拉, 巴拿马, 乌拉圭, 智利, 哥斯达黎加, 萨尔瓦多, 瑞士
-
The Hong Kong Polytechnic UniversityProcornea Nederland B.V.完全的
-
Otsuka Beijing Research InstituteOtsuka Pharmaceutical Co., Ltd.未知
-
Dr Joanne CHIU招聘中ALK基因重排阳性 | EGF-R阳性非小细胞肺癌 | EGFR激活突变 | NSCLC | ROS1基因重排 | ROS1 阳性 NSCLC - 活性氧 1 阳性非小细胞肺癌香港